Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
Xiaohong DuXiangyang ZuoFang MengChenfeng HanWei OuyangYu HanYayun GuXin ZhaoFeng XuFrank Xiaofeng QinPublished in: Cell proliferation (2020)
Overall, our findings demonstrate that AZ can exert broad-spectrum antiviral effects against IAV and SARS-CoV-2, and could be served as a potential clinical anti-SARS-CoV-2 drug in emergency as well as a promising lead compound for the development of next-generation anti-IAV drugs.